|
1
|
Sun K, You Q, Zhao M, Yao H, Xiang H and
Wang L: Concurrent primary carcinoid tumor arising within mature
teratoma and clear cell renal cell carcinoma in the horseshoe
kidney: Report of a rare case and review of the literature. Int J
Clin Exp Pathol. 6:2578–2584. 2013.PubMed/NCBI
|
|
2
|
Seker KG, Sam E, Sahin S, Yenice MG, Aktas
AG, Simsek A and Tugcu V: Partial nephrectomy in horseshoe kidney:
Primary carcinoid tumor. Arch Ital Urol Androl. 89:316–318. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Dasari A, Shen C, Halperin D, Zhao B, Zhou
S, Xu Y, Shih T and Yao JC: Trends in the incidence, prevalence,
and survival outcomes in patients with neuroendocrine tumors in the
United States. JAMA Oncol. 3:1335–1342. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Darbà J and Marsà A: Exploring the current
status of neuroendocrine tumours: A population-based analysis of
epidemiology, management and use of resources. BMC Cancer.
19:12262019. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lane BR, Jour G and Zhou M: Renal
neuroendocrine tumors. Indian J Urol. 25:155–160. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
McGarrah PW, Westin G, Hobday TJ, Scales
JA, Ingimarsson JP, Leibovich BC and Halfdanarson TR: Renal
neuroendocrine neoplasms: A Single-center experience. Clin
Genitourin Cancer. 18:e343–e349. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Nguyen AH, O'Leary MP, De Andrade JP,
Ituarte PHG, Kessler J, Li D, Singh G and Chang S: Natural history
of renal neuroendocrine neoplasms: A NET by any other name. Front
Endocrinol (Lausanne). 11:6242512021. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Priemer DS, Montironi R, Wang L,
Williamson SR, Lopez-Beltran A and Cheng L: Neuroendocrine tumors
of the prostate: Emerging insights from molecular data and updates
to the 2016 World health organization classification. Endocr
Pathol. 27:123–135. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yamada Y and Beltran H: Clinical and
biological features of neuroendocrine prostate cancer. Curr Oncol
Rep. 23:152021. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Romero FR, Rais-Bahrami S, Permpongkosol
S, Fine SW, Kohanim S and Jarrett TW: Primary carcinoid tumors of
the kidney. J Urol. 176:2359–2366. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Krishnan B, Truong LD, Saleh G, Sirbasku
DM and Slawin KM: Horseshoe kidney is associated with an increased
relative risk of primary renal carcinoid tumor. J Urol.
157:2059–2066. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chen Y, Shu Y, He L and Wu K: Primary
renal carcinoid tumors: Three case reports. Medicine (Baltimore).
100:e247142021. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Jiang H and Zhang H: Clinical and
pathological features of primary renal well-differentiated
neuroendocrine tumor. Onco Targets Ther. 15:587–596. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Rosenberg JE, Albersheim JA, Sathianathen
NJ, Murugan P and Weight CJ: Five new cases of primary renal
carcinoid tumor: Case reports and literature review. Pathol Oncol
Res. 26:341–346. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Jabaji R, Kern T, Shen D, Chu W and
Merchant M: Primary renal carcinoid tumor: Report of two cases.
Perm J. 24:1972020. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Omiyale AO and Venyo AK: Primary carcinoid
tumour of the kidney: A review of the literature. Adv Urol.
2013:5793962013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yoon JH: Primary renal carcinoid tumor: A
rare cystic renal neoplasm. World J Radiol. 5:328–333. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Mufarrij P, Varkarakis IM, Studeman KD and
Jarrett TW: Primary renal carcinoid tumor with liver metastases
detected with somatostatin receptor imaging. Urology. 65:10022005.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang XH, Lu X, He B, Jiang YX, Yu WJ, Wang
H, Zhang W and Li YJ: Clinicopathologic features of primary renal
neuroendocrine carcinoma. Zhonghua Bing Li Xue Za Zhi. 47:851–856.
2018.(In Chinese). PubMed/NCBI
|
|
20
|
Gu X, Cheng M and Herrera GA: Kidney
carcinoid tumor: Histological, immunohistochemical and
ultrastructural features. Ultrastruct Pathol. 42:18–22. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Rindi G, Mete O, Uccella S, Basturk O, La
Rosa S, Brosens LAA, Ezzat S, de Herder WW, Klimstra DS, Papotti M
and Asa SL: Overview of the 2022 WHO classification of
neuroendocrine neoplasms. Endocr Pathol. 33:115–154. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Maleki Z, Nadella A, Nadella M, Patel G,
Patel S and Kholová I: INSM1, a novel biomarker for detection of
neuroendocrine neoplasms: Cytopathologists View. Diagnostics
(Basel). 11:21722021. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sappenfield R, Gonzalez IA, Cao D and
Chatterjee D: Well-differentiated rectal neuroendocrine tumors:
Analysis of histology, including insulinoma-associated protein 1
expression, and biologic behavior, involving a large cohort of 94
cases. Hum Pathol. 104:66–72. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Deacon MJ, Harvey H, Shah C and Khan A: A
rare case of a large primary renal neuroendocrine tumour: A case
report and brief review of literature. Cureus.
13:e197432021.PubMed/NCBI
|
|
25
|
Moch H, Cubilla AL, Humphrey PA, Reuter VE
and Ulbright TM: The 2016 WHO classification of tumours of the
urinary system and male genital organs-part A: Renal, penile, and
testicular tumours. Eur Urol. 70:93–105. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Plouin PF, Amar L, Dekkers OM, Fassnacht
M, Gimenez-Roqueplo AP, Lenders JW, Lussey-Lepoutre C and Steichen
O; Guideline Working Group, : European Society of Endocrinology
Clinical Practice Guideline for long-term follow-up of patients
operated on for a phaeochromocytoma or a paraganglioma. Eur J
Endocrinol. 174:G1–G10. 2016. View Article : Google Scholar : PubMed/NCBI
|
